Emerging evidence for neurotensin receptor 1 antagonists as novel pharmaceutics in neurodegenerative disorders.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Mini-Reviews in Medical Chemistry

• Publication date

  2009-09-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/138955709789957495PMID 19929816
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis and biological effects of c(Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu) (JMV2012), a new analogue of neurotensin that crosses the blood-brain barrier.

  2008cited by this paper
• Novel insights into GPCR-peptide interactions: mutations in extracellular loop 1, ligand backbone methylations and molecular modeling of neurotensin receptor 1.

  2008cited by this paper
• Increased neurotensin receptor-1 expression during progression of colonic adenocarcinoma.

  2008cited by this paper
• Biology of Neurotensin: Revisited Study

  2008cited by this paper
• Neurotensin receptor involvement in the rise of extracellular glutamate levels and apoptotic nerve cell death in primary cortical cultures after oxygen and glucose deprivation.

  2008cited by this paper
• Neurotensin reduces glutamatergic transmission in the dorsolateral striatum via retrograde endocannabinoid signaling.

  2008cited by this paper
• Neurotensin in the Ventral Pallidum Increases Extracellular γ-Aminobutyric Acid and Differentially Affects Cue- and Cocaine-Primed Reinstatement

  2008cited by this paper
• Neurotensin receptor mechanisms and its modulation of glutamate transmission in the brain: relevance for neurodegenerative diseases and their treatment.

  2007cited by this paper
• Mesolimbic dopamine and cortico-accumbens glutamate afferents as major targets for the regulation of the ventral striato-pallidal GABA pathways by neurotensin peptides.

  2007cited by this paper
• Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting

  2007cited by this paper
• Neurotensin: role in psychiatric and neurological diseases.

  2006cited by this paper
• Glutamate-induced cell death and formation of radicals can be reduced by lisuride in mesencephalic primary cell culture

  2006cited by this paper
• Bioactive analogs of neurotensin: focus on CNS effects.

  2006cited by this paper
• Inactivation of neurotensin and neuromedin N by Zn metallopeptidases.

  2006cited by this paper
• Neurotensin and pain modulation.

  2006cited by this paper
• Neurotensin selectively facilitates glutamatergic transmission in globus pallidus.

  2006cited by this paper
• Involvement of neurotensin in cancer growth: evidence, mechanisms and development of diagnostic tools.

  2006cited by this paper
• Neurotensin and growth of normal and neoplastic tissues.

  2006cited by this paper
• Internalization and recycling properties of neurotensin receptors.

  2006cited by this paper
• The role of neurotensin in central nervous system pathophysiology: what is the evidence?

  2006cited by this paper
• Receptor–receptor interactions as studied with microdialysis. Focus on NTR/D2 interactions in the basal ganglia

  2006cited by this paper
• Brain neurotensin, psychostimulants, and stress--emphasis on neuroanatomical substrates.

  2006cited by this paper
• Interactions between neurotensin receptors and G proteins.

  2006cited by this paper
• Neurotensin Activates GABAergic Interneurons in the Prefrontal Cortex

  2005cited by this paper
• Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8-13) analogues containing non-natural arginine and lysine residues.

  2005cited by this paper
• In vivo behavioral effects of stable, receptor-selective neurotensin[8-13] analogues that cross the blood-brain barrier.

  2005cited by this paper
• Multitasking with neurotensin in the central nervous system

  2005cited by this paper
• Neurotensin enhances endogenous extracellular glutamate levels in primary cultures of rat cortical neurons: involvement of neurotensin receptor in NMDA induced excitotoxicity.

  2004cited by this paper
• Neurotensin depolarizes globus pallidus neurons in rats via neurotensin type-1 receptor.

  2004cited by this paper
• Role of Calcium in Neurotensin-Evoked Enhancement in Firing in Mesencephalic Dopamine Neurons

  2004cited by this paper
• Regulation of DARPP‐32 Thr75 phosphorylation by neurotensin in neostriatal neurons: involvement of glutamate signalling

  2003cited by this paper
• Immunohistochemical distribution of NTS2 neurotensin receptors in the rat central nervous system

  2003cited by this paper
• Improved tumor selectivity of radiolabeled peptides by receptor and antigen dual targeting in the neurotensin receptor model.

  2002cited by this paper
• Presynaptic action of neurotensin on cultured ventral tegmental area dopaminergic neurones.

  2002cited by this paper
• Neurotensin enhances glutamate excitotoxicity in mesencephalic neurons in primary culture

  2002cited by this paper
• Neurotensin-induced modulation of dopamine D2 receptors and their function in rat striatum: Counteraction by a NTR1-like receptor antagonist

  2002cited by this paper
• Neurotensin analogs indications for use as potential antipsychotic compounds.

  2002cited by this paper
• High‐affinity neurotensin receptors in the rat nucleus accumbens: Subcellular targeting and relation to endogenous ligand

  2001cited by this paper
• Nigral neurotensin receptor regulation of nigral glutamate and nigroventral thalamic GABA transmission: a dual-probe microdialysis study in intact conscious rat brain.

  2001cited by this paper
• Modulation of glutamate neurotoxicity on mesencephalic dopaminergic neurons in primary cultures by the presence of striatal target cells

  2000cited by this paper
• Neurotensin: peptide for the next millennium.

  2000cited by this paper
• Neurotensin increases endogenous glutamate release in rat cortical slices.

  2000cited by this paper
• Distribution of the neurotensin receptor NTS1 in the rat CNS studied using an amino-terminal directed antibody.

  2000cited by this paper
• Identification of Residues Involved in Neurotensin Binding and Modeling of the Agonist Binding Site in Neurotensin Receptor 1*

  2000cited by this paper
• Synthesis and human neurotensin receptor binding activities of neurotensin(8-13) analogues containing position 8 alpha-azido-N-alkylated derivatives of ornithine, lysine, and homolysine.

  1999cited by this paper
• Pivotal role of an aspartate residue in sodium sensitivity and coupling to G proteins of neurotensin receptors.

  1999cited by this paper
• Neurotensin and neurotensin receptors.

  1999cited by this paper
• Neurotensin is an antagonist of the human neurotensin NT2 receptor expressed in Chinese hamster ovary cells.

  1998cited by this paper
• Widespread expression in adult rat forebrain of mRNA encoding high‐affinity neurotensin receptor

  1998cited by this paper
• The Striatal Neurotensin Receptor Modulates Striatal and Pallidal Glutamate and GABA Release: Functional Evidence for a Pallidal Glutamate–GABA Interaction via the Pallidal–Subthalamic Nucleus Loop

  1998cited by this paper
• Characterization of binding sites of a new neurotensin receptor antagonist, [3H]SR 142948A, in the rat brain.

  1998cited by this paper
• Neurotensin and neuroendocrine regulation.

  1997cited by this paper
• Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist.

  1997cited by this paper
• Cellular distribution of neurotensin receptors in rat brain: Immunohistochemical study using an antipeptide antibody against the cloned high affinity receptor

  1996cited by this paper
• Properties of a slow nonselective cation conductance modulated by neurotensin and other neurotransmitters in midbrain dopaminergic neurons.

  1996cited by this paper
• Structure, Functional Expression, and Cerebral Localization of the Levocabastine-Sensitive Neurotensin/Neuromedin N Receptor from Mouse Brain

  1996cited by this paper
• Alterations in peptide levels in Parkinson's disease and incidental Lewy body disease.

  1996cited by this paper
• Proposed Ligand Binding Site of the Transmembrane Receptor for Neurotensin(8–13)*

  1996cited by this paper
• Molecular cloning of a levocabastine‐sensitive neurotensin binding site

  1996cited by this paper
• Receptor‐Receptor Interactions and Their Relevance for Receptor Diversity

  1995cited by this paper
• Pharmacological and Biochemical Profiles of Unique Neurotensin 8-13 Analogs Exhibiting Species Selectivity, Stereoselectivity, and Superagonism (*)

  1995cited by this paper
• Characterization of neurotensin-like immunoreactivity in human basal ganglia: increased neurotensin levels in substantia nigra in Parkinson's disease.

  1995cited by this paper
• Neurochemical changes following occlusion of the middle cerebral artery in rats.

  1995cited by this paper
• Permeability of the blood-brain barrier to the neurotensin8-13 analog NT1.

  1995cited by this paper
• Neurotensin increases endogenous glutamate release in the neostriatum of the awake rat

  1995cited by this paper
• Strong effects of NT/NN peptides on DA D2 receptors in rat neostriatal sections.

  1994cited by this paper
• Neurotensin receptor expression in the rat forebrain and midbrain: A combined analysis by in situ hybridization and receptor autoradiography

  1994cited by this paper
• Rapid desensitization of agonist-induced calcium mobilization in transfected PC12 cells expressing the rat neurotensin receptor.

  1994cited by this paper
• Neurotensin excitation of rat ventral tegmental neurones.

  1994cited by this paper
• Facilitation of GABA release by neurotensin is associated with a reduction of dopamine release in rat nucleus accumbens.

  1994cited by this paper
• The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypes

  1994cited by this paper
• Neurotensin and cholecystokinin octapeptide control synergistically dopamine release and dopamine D2 receptor affinity in rat neostriatum.

  1993cited by this paper
• Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor.

  1993cited by this paper
• Neurotensin stimulates cyclic AMP formation in CHO-rNTR-10 cells expressing the cloned rat neurotensin receptor.

  1993cited by this paper
• The C-terminal neurotensin-(8-13) fragment potently modulates rat neostriatal dopamine D2 receptors.

  1993cited by this paper
• Effects of neurotensin on the release of glutamic acid in the prefrontal cortex and striatum of the rat.

  1993cited by this paper
• Evidence for a substrate of neuronal plasticity based on pre- and postsynaptic neurotensin-dopamine receptor interactions in the neostriatum.

  1992cited by this paper
• Mesencephalic dopaminergic neurons in primary cultures express functional neurotensin receptors

  1992cited by this paper
• Structure-activity studies of neurotensin on muscular rigidity and tremors induced by 6-hydroxydopamine lesions in the posterolateral hypothalamus of the rat.

  1991cited by this paper
• The neurobiology of neurotensin: focus on neurotensin-dopamine interactions.

  1991cited by this paper
• Neurotensin Decreases the Affinity of Dopamine D2 Agonist Binding by a G Protein‐Independent Mechanism

  1991cited by this paper
• Localization of neuropeptide receptor mRNA in rat brain: initial observations using probes for neurotensin and substance P receptors.

  1990cited by this paper
• Heterologous desensitization of bradykinin-induced phosphatidylinositol response and Ca2+ mobilization by neurotensin in NG108-15 cells.

  1989cited by this paper
• Neurotensin stimulates inositol trisphosphate-mediated calcium mobilization but not protein kinase C activation in HT29 cells. Involvement of a G-protein.

  1989cited by this paper
• Hypothermic effect of neuromedin N in mice and its potentiation by peptidase inhibitors.

  1988cited by this paper
• Potentiation by thiorphan and bestatin of the naloxone-insensitive analgesic effects of neurotensin and neuromedin n.

  1988cited by this paper
• Stimulation of Inositol Phosphate Production by Neurotensin in Neuroblastoma N1E115 Cells: Implication of GTP‐Binding Proteins and Relationship with the Cyclic GMP Response

  1987cited by this paper
• Neurotensin reduces the affinity of D-2 dopamine receptors in rat striatal membranes.

  1987cited by this paper
• Neurotensin Stimulates Inositol Phospholipid Metabolism and Calcium Mobilization in Murine Neuroblastoma Clone N1E‐115

  1986cited by this paper
• Neurotensin and its analogs--correlation of specific binding with stimulation of cyclic GMP formation in neuroblastoma clone N1E-115.

  1986cited by this paper
• The interaction of neurotensin with dopaminergic pathways in the central nervous system: basic neurobiology and implications for the pathogenesis and treatment of schizophrenia.

  1986cited by this paper
• Neurotensin-mediated inhibition of cyclic AMP formation in neuroblastoma N1E115 cells: involvement of the inhibitory GTP-binding component of adenylate cyclase.

  1986cited by this paper
• Neurotensin depolarizes substantia nigra dopamine neurones.

  1985cited by this paper
• Neurotensin stimulates inositol phospholipid hydrolysis in rat brain slices.

  1984cited by this paper
• Neurotensin analogs [D-TYR11] and [D-PHE11]neurotensin resist degradation by brain peptidases in vitro and in vivo.

  1983cited by this paper
• STRUCTURE‐ACTIVITY STUDIES WITH NEUROTENSIN: ANALYSIS OF POSITIONS 9, 10 and 11

  1980cited by this paper
• Alterations in nociception and body temperature after intracisternal administration of neurotensin, beta-endorphin, other endogenous peptides, and morphine.

  1979cited by this paper
• Neurotensin analogues. Structure--activity relationships.

  1977cited by this paper
• The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami.

  1973cited by this paper

• The role of peptidase neurolysin in neuroprotection and neural repair after stroke

  2020cites this paper
• Peptidase neurolysin functions to preserve the brain after ischemic stroke in male mice

  2020cites this paper
• Impact of polyphenols on receptor–ligand interactions by NMR: the case of neurotensin (NT)–neurotensin receptor fragment (NTS1) complex

  2020cites this paper
• Regional and Cellular Mapping of Sortilin Immunoreactivity in Adult Human Brain

  2019cites this paper
• Peptidase neurolysin is an endogenous cerebroprotective mechanism in acute neurodegenerative disorders.

  2019cites this paper
• Neuroprotective Effects of Brain-Gut Peptides: A Potential Therapy for Parkinson’s Disease

  2019cites this paper
• Assessments in Primary Parkinson Syndrome for comparison between Monodopaminergic and Multi-target Anti-parkinsonian Pharmacotherapies

  2017cites this paper
• Neurotensin: A role in substance use disorder?

  2016cites this paper
• Classical Neurotransmitters and Neuropeptides involved in Parkinson's Disease: A Multi-Neurotransmitter System

  2014cites this paper
• Dopamine D2 heteroreceptor complexes and their receptor-receptor interactions in ventral striatum: novel targets for antipsychotic drugs.

  2014cites this paper
• Functional up‐regulation of endopeptidase neurolysin during post‐acute and early recovery phases of experimental stroke in mouse brain

  2014cites this paper
• Neurotensin NTS1-dopamine D2 receptor-receptor interactions in putative receptor heteromers: relevance for Parkinson's disease and schizophrenia.

  2014cites this paper
• A machine-assisted flow synthesis of SR48692: a probe for the investigation of neurotensin receptor-1.

  2013cites this paper
• Relative Higher Hematocrit Attenuates the Cerebral Excitatory Amino Acid Elevation Induced by Deep Hypothermic Circulatory Arrest in Rats

  2013cites this paper
• Diagnostics, rehabilitation and models of Parkinson’s disease

  2012cites this paper
• Relevance of dopamine D(2)/neurotensin NTS1 and NMDA/neurotensin NTS1 receptor interaction in psychiatric and neurodegenerative disorders.

  2012cites this paper
• Neurotensin as Modulator of Basal Ganglia- Thalamocortical Motor Circuit – Emerging Evidence for Neurotensin NTS1 Receptor as a Potential Target in Parkinson's Disease

  2012cites this paper
• Striatal NTS1, dopamine D2 and NMDA receptor regulation of pallidal GABA and glutamate release – a dual‐probe microdialysis study in the intranigral 6‐hydroxydopamine unilaterally lesioned rat

  2012cites this paper
• Neurotensin regulates cortical glutamate transmission by modulating N‐methyl‐D‐aspartate receptor functional activity: An in vivo microdialysis study

  2011cites this paper